IBS delivers new Pharma software to Oriola in Finland
IBS delivers new Pharma software to Oriola in Finland Oriola has signed an order for IBS Pharma, IBS' new software for pharmaceutical distribution. Oriola, with an annual revenue of approximately 600 million euros, is a leading Finnish wholesaler and distributor of pharmaceuticals and healthcare products. With the new software, Oriola can improve its supply chain management and logistics. The order is one of the largest for IBS Finland. "The Oriola order is the first for our recently launched IBS Pharma software," says Staffan Ahlberg, CEO for the IBS Group. "IBS Pharma is based on IBS'